Publications

Integrative clinical and preclinical studies identify FerroTerminator1 as a potent therapeutic drug for MASH

 53
Integrative clinical and preclinical studies identify FerroTerminator1 as a potent therapeutic drug for MASH

Tags:

Previous Article

Human Schwann cell lipid dysregulation and plasma membrane perturbation in Charc...

Next Article

FerroTerminator1 as a potent therapeutic drug for MASH

Related Posts

Cells and circuits for amygdala neuroplasticity in the transition to chronic pain

Cells and circuits for amygdala neuroplasticity in the ...

 47

General anesthesia activates a central anxiolytic center in the BNST

General anesthesia activates a central anxiolytic cente...

 47

γ-Secretase in Alzheimer’s disease

γ-Secretase in Alzheimer’s disease

 44